Update on myocarditis following mRNA COVID-19 vaccination
Long-Term Outcome of Fulminant Myocarditis as Compared with Acute (Nonfulminant) Myocarditis | NEJM
The effects of gender and age on occurrence of clinically suspected myocarditis in adulthood | Heart
Here's all the data on myocarditis cases linked to COVID-19 vaccines | Ars Technica
JPM | Free Full-Text | Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types
Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC ...
Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021 | MMWR
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization | NEJM
Role of electrocardiograms in assessment of severity and analysis of the characteristics of ST elevation in acute myocarditis: A two‑centre study
Evolution of acute myocarditis in a pediatric population: An MRI based study - International Journal of Cardiology
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents | NEJM
Increased risk of myocarditis and pericarditis and reduced likelihood of severe clinical outcomes associated with COVID-19 vaccination: a cohort study in Lombardy, Italy | BMC Infectious Diseases | Full Text
CDC says there's likely link between rare heart inflammation in young people after Covid shot
Lack of evidence of significant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens - eBioMedicine
KoreaMed Synapse
NEJM on X: "Among 2.5 million patients who received the BNT162b2 mRNA vaccine in a large Israeli health care system, the incidence of myocarditis at 42 days was 2.13 cases per 100,000
Myocarditis mortality with and without COVID-19: insights from a national registry | Clinical Research in Cardiology
SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study | The BMJ
Myocarditis following mRNA COVID-19 vaccination
Overview of Myocarditis Cases Caused by the COVID-19 Vaccine | DAIC
JCM | Free Full-Text | Occurrence, Trends, Management and Outcomes of Patients Hospitalized with Clinically Suspected Myocarditis—Ten-Year Perspectives from the MYO-PL Nationwide Database
French study on cardiovascular disease incidence during COVID pandemic and vaccination campaign
Abstract 11463: Epidemiological Trends and Outcomes of Acute Myocarditis in the National Health Service of England | Circulation
Trends in myocarditis incidence, complications and mortality in Sweden from 2000 to 2014 | Scientific Reports
Reporting of immune checkpoint inhibitor-associated myocarditis - The Lancet
Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database | Nature Communications
Frontiers | Global, Regional, and National Burden of Myocarditis and Cardiomyopathy, 1990–2017
Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021 | MMWR